A prospective cohort study of Chinese medicine intervention in overweight/obese patients with abnormal glucose tolerance (IGT)
- Conditions
- Diabetes
- Registration Number
- ITMCTR2100004233
- Lead Sponsor
- The Affiliated Hospital of Changchun University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1) Aged 18 to 75 years;
2) Meet the diagnostic criteria of Western medicine for IGT;
3) Meet the diagnostic criteria of western medicine for overweight/obese or central obesity;
4) Informed consent has been signed.
1) Patients who have been diagnosed with type 1 diabetes, type 2 diabetes, gestational diabetes, secondary diabetes and other special types of diabetes;
2) People who have used hypoglycemic drugs continuously in recent 3 months;
3) Patients with severe other diseases or mental disorders;
4) Allergic to the known ingredients of the study drug and allergic constitution;
5) Pregnant or lactating women and those who have recently had family planning;
6) Patients with impaired liver and kidney function (ALT and AST are twice higher than the upper limit of normal value, and serum creatinine is abnormal).
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method